|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS12352 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:50-200 |
| CAS編號(hào) | |
| 抗體名 | Anti-SDHC |
| 克隆性 | 是 |
| 靶點(diǎn) | 詳見說(shuō)明書 |
| 適應(yīng)物種 | 詳見說(shuō)明書 |
| 形態(tài) | 詳見說(shuō)明書 |
| 宿主 | 詳見說(shuō)明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說(shuō)明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Succinate dehydrogenase complex subunit C/SDHC |
產(chǎn)品訂購(gòu)信息：
英文名稱 Anti-SDHC
中文名稱 琥珀酸細(xì)胞色素亞基B560抗體說(shuō)明書
別 名 mitochondrial; QPs1; C560_HUMAN; CYBL; Integral membrane protein CII-3; QPs-1; sdhC; Succinate dehydrogenase complex subunit C; Succinate dehydrogenase cytochrome b560 subunit; Succinate dehydrogenase cytochrome b560 subunit, mitochondrial precursor; Succinate-ubiquinone oxidoreductase cytochrome B large subunit.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 發(fā)育生物學(xué) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 15kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Succinate dehydrogenase complex subunit C/SDHC
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
琥珀酸細(xì)胞色素亞基B560抗體說(shuō)明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:50-200
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone.
Function : Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q).
Subunit : Component of complex II composed of four subunits: the flavoprotein (FP) SDHA, iron-sulfur protein (IP) SDHB, and a cytochrome b560 composed of SDHC and SDHD.
Subcellular Location : Mitochondrion inner membrane.
DISEASE : Defects in SDHC are the cause of paragangliomas type 3 (PGL3) [MIM:605373]. A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas are most commonly located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear.
Defects in SDHC are a cause of paraganglioma and gastric stromal sarcoma (PGGSS) [MIM:606864]; also known as Carney-Stratakis syndrome. Gastrointestinal stromal tumors may be sporadic or inherited in an autosomal dominant manner, alone or as a component of a syndrome associated with other tumors, such as in the context of neurofibromatosis type 1 (NF1). Patients have both gastrointestinal stromal tumors and paragangliomas. Susceptibility to the tumors was inherited in an apparently autosomal dominant manner, with incomplete penetrance.
Similarity : Belongs to the cytochrome b560 family.
Involvement in disease:Defects in SDHC are the cause of hereditary paragangliomas type 3 (PGL3) [MIM:605373]; also known as autosomal dominant non-chromaffin paragangliomas type 3. Non-chromaffin paragangliomas are usually benign, neural crest derived tumors of parasympathetic ganglia.
Defects in SDHC are a cause of paraganglioma and gastric stromal sarcoma (PGGSS) ; also known as Carney-Stratakis syndrome. Gastrointestinal stromal tumors may be sporadic or inherited in an autosomal dominant manner, alone or as a component of a syndrome associated with other tumors, such as in the context of neurofibromatosis type 1 (NF1). Patients have both gastrointestinal stromal tumors and paragangliomas. Susceptibility to the tumors was inherited in an apparently autosomal dominant manner, with incomplete penetrance.
甘露醇卵黃多粘菌素瓊脂平板(MYP)2838mX20個(gè)用于蠟樣芽孢桿菌的菌數(shù)測(cè)定及分離培養(yǎng)(GB/T4789.28-2003中4.64，GB/T4789.03，SN02和...
土霉素葡萄糖酵母提取物選擇性培養(yǎng)基(OGYE培養(yǎng)基) (CM0545) Oxoid incubation media 土霉素葡萄糖酵母提取物選擇性培養(yǎng)基(OGYE培養(yǎng)基) (CM0545) Oxoid
炭黑曲霉 分離源：發(fā)酵劑 支/瓶
心浸液瓊脂250g用于培養(yǎng)營(yíng)養(yǎng)要求高的微生物
克氏雙糖鐵瓊脂 250g 用于細(xì)菌復(fù)合生化試驗(yàn)(葡
甘露醇鹽瓊脂(USP)250g用于金黃色葡萄球菌選擇性分離培養(yǎng)
金黃色葡萄球菌顯色培養(yǎng)基 1000 mL/瓶 incubation media 金黃色葡萄球菌顯色培養(yǎng)基 1000 mL/瓶
PALCAM瓊脂凍干配套試劑 10支 每支添加于100ml(026070)中配成PALCAM瓊脂。
瓊脂培養(yǎng)基NAgarmediumN(Cetrimideagar)用于綠膿假單胞菌的分離培養(yǎng)。
LactobacillusSelectiveAgar
SSDC培養(yǎng)基(ISO)250g用于小腸耶爾森氏菌的分離培養(yǎng)
MKTTn肉湯 MKTTn Broth 用于食品中沙門氏菌檢驗(yàn)選擇性增菌(ISO標(biāo)準(zhǔn))
豬膽汁粉 Bile powder of pig 100克 BR
Raka-Ray3號(hào)培養(yǎng)基250g/瓶用于啤酒和釀造過程中乳酸菌的分離incubationmediaRaka-Ray3號(hào)培養(yǎng)基250g/瓶用于啤酒和釀造過程中乳酸菌的分離
TTC溶液(0.125%) 2ml*5 添加于HB0127中
CL-0202Saos-2(人細(xì)胞)5×106cells/瓶×2
TNFRSF14 Others Mouse 小鼠 HVEM / TNFRSF14 CHO細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人雪旺細(xì)胞cDNAHSC cDNA
豬內(nèi)皮細(xì)胞;ZYM-SVEC01 細(xì)胞，SW1353細(xì)胞 EMT-6細(xì)胞，小鼠癌細(xì)胞株
人整合SV40基因的上皮細(xì)胞;HBL-100 [HBL100]
HA Others H1N1 甲型 H1N1 (A/WSN/1933) 血凝素HA1 (Hemagglutinin) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
琥珀酸細(xì)胞色素亞基B560抗體說(shuō)明書CL-0200RWPE1(人上皮細(xì)胞)5×106cells/瓶×2
PBK Others Human 人 PDK / PDZ binding kinase / TOPK 桿狀病毒-昆蟲細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人少突膠質(zhì)前體細(xì)胞cDNAHOPC cDNA
MCF-7細(xì)胞，人癌細(xì)胞 人肺鱗癌細(xì)胞,LTEP-s細(xì)胞 滑膜細(xì)胞Many types of cells包裝：5 × 105次方(1ml)
犬腎細(xì)胞系/野生型;MDCK/wild
PLAT Others Human 人 tPAβ 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 琥珀酸細(xì)胞色素亞基B560抗體說(shuō)明書 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定：
1）琥珀酸細(xì)胞色素亞基B560抗體說(shuō)明書 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
|
|
|
|
|
